Back to News
Market Impact: 0.3
GSK to shut vaccine factory in Germany, putting 641 jobs at risk
Source: reuters.com
Healthcare & BiotechM&A & Restructuring
GSK will shut its Dresden, Germany vaccine factory in summer 2027. The site produces influenza and hepatitis vaccines, making the closure a negative operational restructuring development that could affect GSK's vaccine manufacturing footprint and local supply capacity.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
moderately negative
Sentiment Score
-0.45
Ticker Sentiment
GSK-0.50
More News
- GSK to close German vaccine plant, 641 jobs at risk
- Apollo in talks to buy J&J orthopedics unit for nearly $20 billion
- Why ACV Stock Rocketed 44% Higher Today
- Apollo Global in talks to acquire J&J’s orthopedics unit, Bloomberg News reports
- Federal budget deficit reaches $2T in first 11 months of fiscal year 2026, CBO reports
- Scholar Rock Announces FDA Approval of ISEMBYLD™ (apitegromab-mstn), the First and Only Muscle-Targeted Treatment for Children and Adults with Spinal Muscular Atrophy (SMA)